Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-gamma secretion in T cells, and inhibits tumor growth in vivo[1].
Molecular Weight:
(145.52 kDa)
Purity:
99.82
CAS Number:
[2249882-54-8]
Target:
PD-1/PD-L1
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
